HeyJaredLongevity.Technology UNLOCKED
Longevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living.
- Indexed episodes, last 90 days
- 22
- Latest publication
- Sep 21, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 3, 2026
Latest episodes
Menopause Changes the Brain More Than We Realised (opens the original)
Read excerpt
Sponsor: Sooo.me Sooo.me™ is a longevity-focused nutraceutical brand offering science-backed supplements designed to support healthy aging, energy, focus, cellular health, and overall wellbeing. Its range combines high-purity ingredients, medicinal mushroom extracts, and targeted formulations with an emphasis on quality, transparency, and sustainable packaging. See what it can do for you — click below to try it today and use code LONGEVITYTECHNO for 10% off. Link: https://sooo.me/?ref=LTUNLOCKED
Can You Make Your Brain 5 Years Younger? (opens the original)
Read excerpt
Guests: Paola Telfer Founder and CEO of Sens.ai LinkedIn: www.linkedin.com/in/paolatelfer/ Website: sens.ai/ Eric Verdin, MD President and CEO of the Buck Institute for Research on Aging LinkedIn: www.linkedin.com/in/eric-verdin-md/ Website: www.buckinstitute.org/ ---------- What if we could track brain aging through function, not just structure? Phil Newman sits down with Paola Telfer, founder and CEO of Sens.ai, and Eric Verdin, president and CEO of the Buck Institute for Research on Aging, to
The Smart Ring Accuracy Crisis | Longevity News Roundup — Week 37, 2026 (opens the original)
Read excerpt
In this week’s Longevity News Roundup, Phil Newman examines Oura’s IPO and sleep suit, movement context in dementia, dog gene therapy, Rentosertib biological clocks, and women's health. ŌURA filed for a $16 billion IPO on Nasdaq under ticker Oura, seeking to raise up to $3 billion. Simultaneously, the smart ring company is defending its sleep stage tracking accuracy in a California class action lawsuit alleging its metrics are no better than a coin flip. A 74-study review of 4.2 million people s
Will AI Make Death Optional? (opens the original)
Read excerpt
What would have to be true for AI to genuinely change the trajectory of human aging? The answer is more complicated than simply discovering an “anti-aging drug.” AI is already compressing parts of drug discovery, with one AI-designed candidate reaching Phase 2 trials in under 30 months, while new biological aging clocks could allow researchers to measure changes in months rather than decades. But aging is not a single disease. It involves interconnected processes including cellular senescence, m
The $820 Million Bet to Transform Hair Loss Treatment | Longevity News Roundup - Week 36, 2026 (opens the original)
Read excerpt
In this week’s Longevity News Roundup, Phil Newman examines the developments reshaping longevity and healthspan, from a major biotech investment in hair loss to AI-driven drug repurposing, the industry’s communication challenge, biological-age testing at population scale, and the push to manufacture regenerative cell therapies in the US. Veradermics has built an $820 million war chest to advance VDPHL01, an extended-release oral formulation of minoxidil for male and female pattern hair loss. Pha
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.